Your AI-Trained Oncology Knowledge Connection!

Julie M. Vose, MD, MBA

home / authors / julie-m-vose-md-mba

Articles

Combining New Therapies and MRD Approaches Across Lymphomas

August 31st 2024

Julie Vose, MD, discusses the exciting developments across lymphomas.

Rationale for Genetic Testing in Patients With DLBCL

Julie M. Vose, MD, MBA

November 19th 2018

Julie M. Vose, MD, MBA, discusses the importance of conducting genetic testing on all patients with diffuse large B-cell lymphoma to better understand their disease and treat the disease properly.

Overcoming BTK Inhibitor Resistance in NHL

Julie M. Vose, MD, MBA

October 19th 2018

Julie M. Vose, MD, MBA, discusses resistance to BTK inhibitors in patients with non-Hodgkin lymphoma.

Exploring Novel Agents to Target Pathways in Lymphoma

Julie M. Vose, MD, MBA

August 9th 2018

Julie M. Vose, MD, MBA, Chief in the Division of Oncology/Hematology at the University of Nebraska Medical Center, discusses strategies for overcoming resistance in lymphoma during the 2018 Pan Pacific Lymphoma Conference. 